A

Atlas Oncology Partners

Full-risk, value-based oncology care

Vice President Technology & Data

Full-Time
$200k - $225k/yr
Expert
Bachelor's
Remote in USA+3 moreMore locations: Boston, MA, USA | Nashville, TN, USA | Memphis, TN, USA
Remote
Engineering ManagementEngineering Leadership

About the job

Requirements
  • A bachelor's degree or equivalent experience is required.
  • Five to ten years of experience in healthcare IT, data, and/or product leadership is required.
  • Basic competency as both a data engineer and data warehouse administrator, with a history of prior healthcare deployments, is required.
  • Fluency with modern AI solutions is required.
  • Experience with product strategy, build-versus-buy decisions, and user needs research is required.
  • Prior expertise managing and contracting key technology vendors is required.
  • Proficiency in performing data analyses in Excel and summarizing executive-friendly output in PowerPoint, including performance dashboards, is required.
  • Strong organizational skills and high attention to detail are required.
  • The ability to think critically, solve problems, and translate ideas into action is required.
  • The ability to manage multiple priorities in a fast-paced environment is required.
Responsibilities
  • Build short- and long-term technology and data roadmaps and use Atlas' core competencies to drive build-versus-buy decisions.
  • Architect the data warehouse and reporting infrastructure supporting corporate outcome measures and continuous improvement.
  • Design and maintain data feeds required for an intelligent value-based care operation in partnership with interoperability and data warehouse vendors.
  • Ensure Atlas uses modern AI tools to power its technology and data infrastructure.
  • Code and deploy data pipelines (ETL/ELT) directly and serve as interim database administrator while building the team.
  • Lead the team spanning IT and information security, data engineering, help desk, and EMR specialists.
  • Set direction and accountability for day-to-day technology issues, including outages, vendor escalations, security threats, and SLA breaches, with the Director of IT and Information Security owning execution.
  • Champion the technology vision internally, to the board, and to current and prospective partners.
  • Represent Atlas technology to practice partners from diligence through implementation and run-rate operations.
  • Support implementation for new payer and provider clients.
  • Recruit and manage a team supporting daily technology operations and information security.
  • Accelerate adoption of AI tools by corporate and clinic-based teams.
  • Partner with leadership and cross-functional teams to understand user needs, develop a technology and data roadmap, and execute alongside Atlas and partner oncology practice teams.
  • Lead data and insights as a product.
Desired Qualifications
  • Experience in a high-growth startup is preferred.
  • Experience in outpatient value-based care primary care is preferred.
  • Experience working with Claude CODE CLI or IDE Extension via Claude API is preferred.

About the company

A

Atlas Oncology Partners

View

Atlas Oncology Partners embeds an interdisciplinary Extended Care Team into community oncology practices and assumes full medical cost risk with payers under outcomes-based contracts. The Extended Care Team—physicians, nurses, patient navigators, and social workers—delivers wrap-around services, including proactive care coordination, 24/7 symptom triage, management of cancer-adjacent conditions, psychosocial support, and supportive care, with same- or next-day access to care to reduce ER visits. The platform unifies multiple data sources to provide actionable insights for providers and staff, and Atlas funds infrastructure, technology, and staff for partner practices to align incentives with high-value care. The company plans to expand across the Southeast (Alabama, Arkansas, Louisiana, Texas) with a goal of improving patient outcomes and experiences while lowering total cancer care costs.

Company Size

11-50

Company Stage

Series A

Total Funding

$28M

Headquarters

Nashville, Tennessee

Founded

2025

Get referred to Atlas Oncology Partners

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Atlas hired Robert Sepucha as CEO on September 1, 2026, signaling scaling discipline.
  • Atlas now partners across three states and targets four markets by year-end 2026.
  • Rubicon and Flare promised up to $100 million more capital, funding Southeast expansion.

What critics are saying

  • Atlas depends on Humana Medicare Advantage volume in Tennessee and Mississippi through 2026.
  • Full medical-cost risk makes one bad claims year threaten Atlas's entire balance sheet.
  • One partner, West Cancer Center, limits density; provider defections can break expansion plans.

What makes Atlas Oncology Partners unique

  • Rubicon Founders incubated Atlas; Flare Capital led its $28M Series A on February 11, 2026.
  • Atlas embeds local interdisciplinary care teams inside community oncology practices, not centralized virtual call centers.
  • Humana launched Atlas coverage January 1, 2026, validating payer demand for full-risk oncology contracts.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Vacation
  • Paid Holidays
  • Paid Sick Leave

Growth & Insights and Company News

Headcount

6 month growth

6%

1 year growth

6%

2 year growth

6%
The Pharma Data
Feb 12th, 2026
Atlas Oncology Partners Secures $28M Series A Funding to Expand Value-Based Cancer Care

Atlas Oncology Partners secures $28M Series A funding to expand value-based cancer care. Atlas Oncology Partners raises $28M Series A to scale value-based oncology care. * Atlas Oncology Partners is a value-based oncology enablement platform that embeds interdisciplinary care teams into community oncology practices and assumes full medical cost risk to improve patient outcomes and experience. Atlas Oncology Partners today announced the closing of its Series A financing. Atlas was founded by Rubicon Founders, a healthcare investment firm focused on building and growing companies that transform the way people receive care. The financing round was led by Flare Capital Partners with significant participation from Rubicon Founders. The $28 million funding round will be used to expand Atlas' geographic footprint with more oncology practice partners and invest in clinical and operational infrastructure. Cancer care is often fragmented, forcing patients to navigate multiple providers while managing complex clinical and social needs. Atlas was founded to address these challenges by embedding interdisciplinary care teams - providers, nurses, patient navigators, and social workers - directly into oncology practices, enabling coordinated, patient-centered care during and beyond active treatment. "From the moment of diagnosis, patients can feel overwhelmed by the complexity of cancer care," said Kate Barnard Roberts, President and Co-Founder of Atlas Oncology Partners. "Atlas was built to simplify that experience by embedding holistic, coordinated support into oncology practices. This investment enables us to scale our model and reach more patients while staying true to our mission of improving quality of life and outcomes." Atlas' model combines patient navigation, psychosocial and supportive care, proactive care coordination, and expanded in-person and virtual clinical access. Atlas assumes full medical cost risk from payors and aligns incentives with a high-value network of medical oncology practice partners. To succeed in these arrangements, Atlas makes investments to support partner operations, leading to high-quality, value-based care that reduces avoidable costs and eases the financial burden on patients. "We incubated and invested in Atlas Oncology Partners to fundamentally rethink how cancer care is delivered," said Matt Kim, Partner at Rubicon Founders. "By embedding interdisciplinary teams directly into oncology practices and assuming full medical cost risk, Atlas is building a scalable model that improves outcomes, experience, and affordability." "Atlas Oncology Partners is addressing one of the most complex and costly areas of healthcare with a model that is deeply aligned with patients, oncologists, and payers at the forefront of value-based care," said Ian Chiang, Partner at Flare Capital Partners. "We are excited to lead their Series A and support Atlas as it scales the next-generation value-based oncology model - one that empowers community oncology groups to deliver coordinated, holistic care at scale and drives impactful clinical outcomes for patients and families impacted by cancer." About Atlas Oncology Partners Atlas Oncology Partners is dedicated to delivering uplifting and responsive cancer care during and beyond treatment. By partnering with leading oncologists and taking full medical cost risk, Atlas offers an innovative solution that delivers better care experiences while easing the economic strain of cancer treatment. About Rubicon Founders Rubicon Founders is an entrepreneurial healthcare investment firm focused on building and growing transformational companies that create enduring value by transforming the way people receive care. Rubicon Founders brings together a core team of investment, operating, and technology professionals who work to put patients and doctors first. About Flare Capital Partners Flare Capital Partners is the leading healthcare technology venture capital firm advancing innovation-driven companies to improve positive health outcomes, broaden care access, and lower healthcare costs. We partner with exceptional founders solving healthcare's hardest challenges, supporting each with our deep sector expertise, unparalleled industry resources, and proven access to commercial opportunities. Our team of established investors and senior operating executives has invested in 70+ companies and has nearly $1 billion in assets under management.

FinSMEs
Feb 11th, 2026
Atlas Oncology Partners Raises $28M in Series A Funding

Atlas Oncology Partners, a Nashville, TN-based provider of a value-based oncology enablement platform, raised $28M in Series A funding